MYCENAX BIOTECH INC. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 43.45 TWD | -0.23% |
|
-6.16% | +21.71% |
Chart calendar Mycenax Biotech Inc.
e.QBoU_DAGGGl3DuaaP5o4v4v4Qs5Kng_VaT6KWLA1uVM.JkhginxidSRAOrXeTOxy2OeiI6gv1E2lIH_hP4hX9DkhL3COQm10CihJsw~c89a0bcdb3545846dae15cec4c062c09
Upcoming events on Mycenax Biotech Inc.
Past events on Mycenax Biotech Inc.
| 2024-04-08 09:16 pm | March 2024 Sales and Revenue Release |
| 2024-03-20 05:29 am | Q4 2023 Earnings Release |
| 2024-03-07 | February 2024 Sales and Revenue Release |
| 2024-02-06 | January 2024 Sales and Revenue Release |
| 2024-01-08 | December 2023 Sales and Revenue Release |
| 2023-11-13 | Q3 2023 Earnings Release |
| 2023-11-08 | October 2023 Sales and Revenue Release |
| 2023-10-11 02:07 am | September 2023 Sales and Revenue Release |
| 2023-09-06 05:01 am | August 2023 Sales and Revenue Release |
| 2023-08-14 05:05 am | Q2 2023 Earnings Release |
| 2023-08-08 | July 2023 Sales and Revenue Release |
| 2023-07-06 | June 2023 Sales and Revenue Release |
| 2023-06-19 | Annual General Meeting |
| 2023-06-05 | May 2023 Sales and Revenue Release |
| 2022-12-26 09:00 pm | Extraordinary Shareholders Meeting |
| 2022-11-10 08:38 pm | Q3 2022 Earnings Release |
| 2016-11-08 | Q3 2016 Earnings Release |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
|
Net sales Million TWD | Released Forecast Spread | 0,00 | 665 661 0.66% | 0,00 | 732 622 17.73% |
|
EBITDA | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 | 0,00 0,00 - |
|
EBIT Million TWD | Released Forecast Spread | 0,00 | 35,4 130 -72.77% | 0,00 | -445 -299 -48.83% |
|
Earnings before Tax (EBT) Million TWD | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 | -463 -290 -59.6% |
|
Net income Million TWD | Released Forecast Spread | -218 | 0,00 0,00 - | -89,9 | -454 -291 -55.89% |
|
EPS TWD | Released Forecast Spread | -1,74 | 0,00 0,00 - | -0,61 | -2,74 -1,88 -45.74% |
| Announcement Date | 19/03/20 | 29/03/21 | 24/03/22 | 14/03/23 |
Quarterly results
| Fiscal Period | December | 2022 Q2 | 2022 Q3 | 2022 Q4 |
|---|---|---|---|---|
|
Net sales Million TWD | Released Forecast Spread | 159 91,0 75.01% | 196 154 27.19% | |
|
EBIT Million TWD | Released Forecast Spread | -163 -89,0 -83.37% | -175 -103 -69.68% | |
|
Earnings before Tax (EBT) Million TWD | Released Forecast Spread | -176 -90,0 -95.76% | -189 -103 -83.6% | |
|
Net income Million TWD | Released Forecast Spread | -116 | -173 -90,0 -92.19% | -183 -103 -77.22% |
|
EPS TWD | Released Forecast Spread | -0,76 | -1,12 -0,44 -154.55% | -0,98 -0,50 -96% |
| Announcement Date | 11/08/22 | 11/11/22 | 14/03/23 |
| Today 04:05 pm | EXELIXIS, INC.: Q1 2024 Earnings Release |
| 2024-04-30 | SUMMIT THERAPEUTICS INC.: Q1 2024 Earnings Release |
| 2024-04-30 | MACROGENICS, INC.: Q1 2024 Earnings Release (Projected) |
| 2024-04-30 | REGENXBIO INC.: Q1 2024 Earnings Release (Projected) |
| 2024-04-30 | DECIPHERA PHARMACEUTICALS, INC.: Q1 2024 Earnings Release (Projected) |
| 2024-05-01 07:00 am | NEUROCRINE BIOSCIENCES, INC.: Q1 2024 Earnings Release |
| 2024-05-01 04:05 pm | SAREPTA THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 2024-05-01 | ZENTALIS PHARMACEUTICALS, INC.: Q1 2024 Earnings Release (Projected) |
| 2024-05-01 | DENALI THERAPEUTICS INC.: Q1 2024 Earnings Release (Projected) |
| 2024-05-01 | GERON CORPORATION: Q1 2024 Earnings Release |
Past sector events for Mycenax Biotech Inc.
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- 4726 Stock
- Calendar Mycenax Biotech Inc.
